Literature DB >> 12161240

Intravenous nesiritide (human B-type natriuretic peptide) reduces plasma endothelin-1 levels in patients with decompensated congestive heart failure.

Doron Aronson1, Andrew J Burger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12161240     DOI: 10.1016/s0002-9149(02)02507-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  9 in total

Review 1.  Nesiritide for acute decompensated heart failure: does the benefit justify the risk?

Authors:  Jonathan Sackner-Bernstein; Keith D Aaronson
Journal:  Curr Cardiol Rep       Date:  2007-05       Impact factor: 2.931

Review 2.  Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure.

Authors:  Clyde W Yancy
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 3.  Nesiritide: a review of its use in acute decompensated heart failure.

Authors:  Gillian M Keating; Karen L Goa
Journal:  Drugs       Date:  2003       Impact factor: 9.546

4.  Treatment with B-type natriuretic peptide for chronic decompensated heart failure: insights learned from the follow-up serial infusion of nesiritide (FUSION) trial.

Authors:  Clyde W Yancy
Journal:  Heart Fail Rev       Date:  2004-07       Impact factor: 4.214

Review 5.  Acute heart failure: patient characteristics and pathophysiology.

Authors:  Catherine N Marti; Vasiliki V Georgiopoulou; Andreas P Kalogeropoulos
Journal:  Curr Heart Fail Rep       Date:  2013-12

6.  Effectiveness of nesiritide on dialysis or all-cause mortality in patients undergoing cardiothoracic surgery.

Authors:  Thomas M Beaver; Almut G Winterstein; Jonathan J Shuster; Tobias Gerhard; Tomas Martin; James A Alexander; Richard J Johnson; Ahsan Ejaz; Abraham G Hartzema
Journal:  Clin Cardiol       Date:  2006-01       Impact factor: 2.882

7.  Prolonged effects of B-type natriuretic peptide infusion on cardiac remodeling after sustained myocardial injury.

Authors:  Isaac George; Brad Morrow; Kai Xu; Geng-Hua Yi; Jeffrey Holmes; Ed X Wu; Zhihe Li; Andrew A Protter; Mehmet C Oz; Jie Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-06-12       Impact factor: 4.733

8.  Plasma N-terminal pro-brain natriuretic peptide: a prognostic marker in patients with chronic obstructive pulmonary disease.

Authors:  Su Young Chi; Eun Young Kim; Hee Jung Ban; In Jae Oh; Yong Soo Kwon; Kyu Sik Kim; Yu Il Kim; Young Chul Kim; Sung Chul Lim
Journal:  Lung       Date:  2012-01-14       Impact factor: 2.584

Review 9.  Efficacy and safety of nesiritide in patients with decompensated heart failure: a meta-analysis of randomised trials.

Authors:  Bojun Gong; Zhineng Wu; Zicheng Li
Journal:  BMJ Open       Date:  2016-01-06       Impact factor: 2.692

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.